Los Angeles, CA, United States of America

Timothy Triche


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Timothy Triche

Introduction

Timothy Triche is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of cancer treatment, particularly in the development of innovative methods for addressing Ewing sarcoma. His work is characterized by a focus on advanced compositions and methodologies that leverage cutting-edge technology.

Latest Patents

Timothy Triche holds a patent for "Compositions and methods for treating Ewing sarcoma." This patent outlines compositions and methods designed to treat cancer in subjects in need. The methods involve the use of hybrid polymerized liposomal nanoparticles that incorporate both polymerizable and non-polymerizable lipids. Additionally, these nanoparticles are equipped with targeting agents and therapeutic agents, enhancing their effectiveness in cancer treatment.

Career Highlights

Throughout his career, Timothy Triche has worked with esteemed organizations such as Children's Hospital Los Angeles and Nanovalent Pharmaceuticals, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Timothy has collaborated with notable colleagues, including Jon O Nagy and Hyung-Gyoo Kang. These partnerships have further enriched his research and development efforts, leading to advancements in cancer treatment methodologies.

Conclusion

Timothy Triche's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His contributions continue to pave the way for new therapeutic approaches to combat Ewing sarcoma and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…